Biotech stocks down at noon
Wednesday, 11 March, 2009
At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.
Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.
Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.
Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.
Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
